TITLE

Bentley enters license deal

PUB. DATE
February 2000
SOURCE
New Hampshire Business Review;02/25/2000, Vol. 22 Issue 5, p16
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Informs that New Hampshire-based Bentley Pharmaceuticals has entered into a non-exclusive licensing agreement with Ethypharm to market the drug Diltiazem Hydrochloride Slow Release in Spain.
ACCESSION #
2896729

 

Related Articles

  • Drug Delivery in Spain.  // Drug Delivery Industry Profile: Spain;November 2004, p1 

    Presents a profile of the Drug Delivery industry in Spain. Background on Datamonitor, a business information company specializing in industry analysis; Executive summary of the industry; Market overview; Market value; Market segmentation; Competitive landscape; Leading companies in the...

  • ETHYPHARM TO DEVELOP A FLASH VERSION OF AVENTIS' ALLEGRA.  // Worldwide Biotech;Jul2002, Vol. 14 Issue 7, p6 

    Reports on a licensing agreement signed by Ethypharm with Aventis.

  • FDA APPROVES MARKETING OF TESTIM TESTOSTERONE REPLACEMENT.  // Biotech Business;Dec2002, Vol. 15 Issue 12, p6 

    Reports on the approval granted by the U.S. Food and Drug Administration for Testim, a patented testosterone replacement therapy gel from Bentley Pharmaceuticals Inc.

  • Testosterone Therapy Gel Based on Novel Delivery Technology. Holland-Moritz, Pam // Drug Discovery & Development;Jan2003, Vol. 6 Issue 1, p23 

    Reports on Bentley Pharmaceuticals Inc.'s Testin, a patented testosterone replacement therapy gel. Drug discovery technology of the company; Mechanism of action.

  • Bentley obtains Spain drug OK.  // New Hampshire Business Review;12/01/2000, Vol. 22 Issue 25A, p21 

    Reports on the approval of the Spanish Ministry of Health for Bentley Pharmaceuticals Inc. to produce and market a generic version of the drug omeprazole in Spain.

  • Bentley Pharmaceuticals obtains Spanish approval. Wood, Peter // Life Science Today;Aug2000, Vol. 1 Issue 4, p4 

    Reports on the drug approval received by the U.S. drug delivery company Bentley Pharmaceuticals Inc. to market a generic version of omeprazole in Spain.

  • Accounts in Action.  // Pharmaceutical Executive;Jun2003, Vol. 23 Issue 6, p86 

    Offers news pertaining to the pharmaceutical industry as of June 2003. Selection of Edelman by AstraZeneca to develop communications programs for its four medicines; Retention of the service of FD Morgen-Walke to handle the investor and media relations of Bentley Pharmaceuticals; Hiring of...

  • Ethypharm and Biovail enter into strategic alliance.  // Pharmaceutical Technology Europe;Jun2002, Vol. 14 Issue 6, p10 

    Announces the strategic alliance between Ethypharm and Biovail Corp. Establishment of licensing and product development program; Terms of the agreement; Development of drug delivery technologies by the companies.

  • Pharma: Other News To Note.  // BioWorld Today;3/ 7/2013, Vol. 24 Issue 44, p7 

    The article offers world news briefs related to the pharmaceutical industry which include the license distribution agreement signed by Grunenthal Group and EthyPharm SA, the $45 million settlement paid by Par Pharmaceutical Cos. Inc., and the agreement signed by Roche AG and BioLamina AB.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics